Johnson & Johnson said Thursday that new data shows that its single-shot COVID-19 vaccine provides protection against the virus for at least eight months and effectively prevents infection from ...

Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.

Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.

NEW BRUNSWICK, N.J. -- Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company ...

NEW BRUNSWICK, N.J. - Johnson & Johnson said Friday it has started testing its COVID-19 vaccine in older children and teenagers, ages 12 to 17. The company said in a statement that it has expanded the ...

STANFORD, Calif. (KGO) -- As concerns grow over the slow pace of COVID-19 vaccinations in the U.S., there's hope that a new option could soon help turn the tide. The vaccine from Johnson & Johnson ...

What kind of vaccine is it? The vaccine uses a weakened cold virus to deliver genes for one of the COVID-19 virus’s key proteins, known as the spike protein—once in the cells, the viral protein ...

Johnson & Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September. The company said it has selected a lead vaccine candidate from constructs it's been working ...

Nearly 4 million doses of Johnson & Johnson's single-dose COVID-19 vaccine are headed to states, including California, with injections expected to start as early as Tuesday. The White House says the ...